Clinical Trials Directory

Trials / Unknown

UnknownNCT03016182

Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery

Effect of Remote Ischemic Preconditioning on Pulmonary Injury in Cardic Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Xuzhou Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

During cardiac surgery with cardiopulmonary bypass , pulmonary dysfunction remains to be a problem complicating the postoperative course of the patients.Remote ischemic preconditioning(RIPC) with transient upper limb ischemia/reperfusion is a novel, simple, cost-free,non-pharmacological and non-invasive strategy.Recent several trials suggested that RIPC could provide pulmonary protection by reducing serum biomarkers,however,whether the RIPC can improve the clinical outcomes in patients undergoing on-pump cardiac surgery,is still uncertain. The study hypothesis is: remote ischemic preconditioning will provide lung-protective effect and improve clinical outcomes in patients undergoing cardic surgery.

Detailed description

Remote ischemic preconditioning (RIPC) protocol will be induced during anesthesia by 3 cycles of 5-min upper limb ischemia and 5-min reperfusion using a blood pressure cuff inflated to a pressure 200mmHg

Conditions

Interventions

TypeNameDescription
PROCEDURERemote Ischemic PreconditioningRIPC will be induced during anesthesia by 3 cycles of 5-min upper limb ischemia and 5-min reperfusion using a blood-pressure cuff inflated to a pressure 200mmHg
PROCEDUREControlControl group witnout remote ischemic preconditioning

Timeline

Start date
2017-02-07
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2017-01-10
Last updated
2017-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03016182. Inclusion in this directory is not an endorsement.